Corcept Therapeutics (CORT) Net Margin Growth (3y) (2015 - 2026)

Corcept Therapeutics (CORT) Net Margin Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 9,283.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -569.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 6,537.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Corcept Therapeutics 9.56 Bn 9.22 Bn 162.02 Mn -3,388.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,388.00
Dec 31, 2025 -422.00
Sep 30, 2025 -2,464.00
Jun 30, 2025 -870.00
Mar 31, 2025 -1,143.00
Dec 31, 2024 -1,573.00
Sep 30, 2024 -612.00
Jun 30, 2024 -752.00
Mar 31, 2024 -1,080.00
Dec 31, 2023 -734.00
Sep 30, 2023 17.00
Jun 30, 2023 -875.00
Mar 31, 2023 -1,730.00
Dec 31, 2022 -1,738.00
Sep 30, 2022 163.00
Jun 30, 2022 -147.00
Mar 31, 2022 -382.00
Dec 31, 2021 -48.00
Sep 30, 2021 416.00
Jun 30, 2021 -24.00